The results revealed that HNRNPC, IGF2BP2 and YTHDF1 are highly expressed in PAAD with powerful evidence, while METTL3 and YTHDC2 are less likely to have differential expression (Fig. 1A). The gene discussed is IGF2BP2; the disease is pancreatic adenocarcinoma.